Armata Pharmaceuticals, Inc. Common Stock (ARMP)
5.2700
+0.00 (0.00%)
NYSE · Last Trade: Oct 28th, 8:27 AM EDT
Could the Next Breakthrough in Antibiotic Resistance Come From Viruses That Kill Bacteria?
Antibiotic resistance has become one of medicine’s most urgent challenges. The CDC estimates that resistant infections cause ~35,000 deaths each year in the U.S. and more than 1 million globally - a number projected to rise sharply over the next 25 years. Traditional drug development is struggling to keep pace, forcing healthcare systems to look beyond antibiotics altogether.
Via AB Newswire · October 28, 2025
This $13M Biotech Has $40M in Pentagon Funding – Here’s Why BiomX Could Be Biotech’s Best-Kept Secret
Via News Direct · June 26, 2025
San Diego, CA -- (SBWIRE) -- 05/20/2021 -- An investigation on behalf of investors in shares of Armata Pharmaceuticals Inc. (NYSE:ARMP) was announced over potential breaches of fiduciary duties by certain officers and directors at Armata Pharmaceuticals Inc. .
Via SBWire · May 20, 2021